A Multicenter, Randomized, Double-blind, Parallel, Placebo-controlled Clinical Study to Evaluate the Efficacy and Safety of a Nicotine Mint Lozenge (2 and 4 mg) in Smoking Cessation.

J Addict Med · 2020 · PMC7012347 · PMID 31658113

Europe PMC DOI

hedged sentence

0.3851

closest p · 7.7× alpha

0.3851

boldest claim

The sentences

did not reach statistical significanceP = 0.3851not close (p > 0.1)

In the 2 mg stratum, the success rates were 24.48% for nicotine versus 21.49% for placebo, which was similar between groups and did not reach statistical significance (OR: 1.22; 95% CI: 0.78–1.92; P = 0.3851).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.